Back to Newsroom

International Stem Cell Corporation to Present Preclinical Parkinson’s Disease Data at Neuroscience 2014

CARLSBAD, CA–(November 18, 2014) – International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today preclinical data from its Parkinson’s disease program. ISCO’s Chief Scientific Officer Ruslan Semechkin, Ph.D., will discuss the data at the “Advances Through Stem Cell Research” press conference at the Society for Neuroscience’s annual meeting at 10 a.m. on Nov. 18 in Washington, D.C.

Click here to read more